Figure 5From: Drug shortages in European countries: a trade-off between market attractiveness and cost containment? Proportion of the reported drugs per route of administration. The proportion of drugs per route of administration is shown for a) overall drug (n = 671), b) essential drugs (n = 200) and c) oncology drugs (n = 71).Back to article page